The aim of this study is to assess the efficacy and safety of SMES combined with NGF for dysphagia after ischemic stroke.<h4>Methods</h4>A total of 144 participants will be randomly assigned to an electroacupuncture (EA) + NGF group, an EA + placebo group, an acupuncture + NGF group, or an acupuncture + placebo group in a ratio of 1:1:1:1. This evidence concerns the gene NGF and ischemic stroke.